HUMIRA
HUMIRA
Approved
DIN Number
02258595
Drug Class
Human
Market Date
Sep 24, 2004
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02258595
AIG Number0150364001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADALIMUMABActive
Strength: 40 MG / 0.8 ML
Monograph: ADALIMUMAB